Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera in STEMI patients (BEAT-STEMI Pilot)
NCT01093820Phase 2Completed
- Sponsor
- University Hospital Basel
- Start
- Apr 2010
- Primary completion
- Sep 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of Epoetin alfa RB in myocardial infarction (MI), sponsored by University Hospital Basel. Started Apr 2010; status: completed.
02
Drugs
Epoetin alfa RB
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT01093820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01093820.